Our Company

marpella-logo-150Marpella’s branded line of natural products and supplements use proven ingredients and technologies to address specific effects as well as overall, foundational health. We are offering formulations that have until now only been available through physician offices. All of Marpella’s supplements contain ingredients that have been classified by the FDA as GRAS (Generally Regarded as Safe). Marpella’s supplements are made from natural ingredients and do not contain cannabis oil. Marpella’s Chief Medical Officer, Lawrence A. May, M.D., has been involved in all of the formulations for Marpella’s supplements. These formulations utilize his expertise as the former head of medical affairs at Herbalife and as the developer of other successful supplements (Prosvent). He is also a leading primary care physician.

Marpella’s flagship supplements include IndiCalm, a relaxant and anxiolytic based on L-theanine; ClearNaze, a natural decongestant without stimulant or drowsiness effects; Satietiva, an amino acid-based appetite suppressant; and EndoCannabinoid Omega-3 Support (or MendΩCan), a highly pure, potent and palatable Omega 3 supplement.

Frequently Asked Questions

Q: What does “Marpella” mean?

A: We chose our company name to reflect our commitment to health.  “Marpe” is Hebrew for health and healing, and “-ella” has components of the founders’ names:  Stella and Lawrence/Larry.

Q: Why natural wellness?

A:  Natural products—amino acids and botanicals—have the power to encourage natural wellness of our bodies and of our minds. The complex phytochemical composition of many plants has changed over time to adapt to different environments for survival, and natural products remain a rich, diverse and undiminished source for healing substances.  Amino acids are the basic building blocks of life, for all neurotransmitters and for all proteins, which regulate nearly every biochemical reaction in the body.  We invite you to try our natural wellness products, which were developed with scientific basis and the finest ingredients (all classified by the FDA as GRAS—Generally Regarded As Safe).  Several of our products are being offered for the first time outside of physicians’ offices.  We proudly believe you will find our natural wellness product line to be a welcome solution for enhancing healing and lifestyle.

Q: What is your product philosophy?

A: At Marpella, we passionately believe in using natural ingredients with known structure/function relationships to create effective alternatives to conventional medications. Often, natural supplements do not have the side effects associated with certain prescription medications. All of our products are designed and formulated with this philosophy in mind. Moreover, we have many testimonials from people who prefer our products to their prescription medications. These testimonials include customers who use TopiCanna instead of prescription Voltaren cream for musculoskeletal pain, Zyrtec and Sudafed users who find effective, fast, gentler relief from ClearNaze, and people suffering from anxiety and/or ADD who prefer IndiCalm for relaxation and focused thinking without the mind altering and habituating effects of benzodiazepines.

Q: Who are the people behind Marpella?

A: Marpella’s co-founders are Stella M. Sung, Ph.D. (CEO) and Lawrence A. May, M.D., F.A.C.P. (Chief Medical Officer). Drs. Sung and May previously served as CEO and CMO respectively of Tauriga Sciences, where they developed the natural wellness product line that is now Marpella’s.

Dr. Stella M. Sung brings over 20 years of leadership experience in the healthcare sector as both a senior operating executive and an early stage life science venture capitalist. In addition to her role as CEO and Co-Founder of Marpella LLC, Dr. Sung is Managing Director of Pearl Street Venture Fund, a life science venture fund. She was Chairman & CEO of Tauriga Sciences and remains Chairman of the Tauriga’s Medical Advisory Board.  Dr. Sung previously held the position of Chief Business Officer of Cylene Pharmaceuticals, a venture-backed oncology company and served as Business Development Officer of Avita Medical, a public regenerative medicine company.  Dr. Sung has served as a Managing Director or General Partner for several life science venture firms, including Coastview Capital (founded by former Amgen CEO Gordon Binder) and Oxford Bioscience Partners. She has led venture rounds of financing for seven transactions, co-founded two biotechnology companies, served on 7 Boards of Directors and served as Chairman of the Board for four biotechnology companies. Previously, she focused on life science and health care investments at Advent International, a global private equity firm that has raised over $6 billion in cumulative capital to date. Dr. Sung received her B.S. in chemistry from The Ohio State University, where she was elected to Phi Beta Kappa and her Ph.D. in chemistry from Harvard University, where she was a National Science Foundation Pre-Doctoral Fellow. She earned her Harvard Ph.D. under the guidance of Professor Dudley Herschbach, the 1986 Nobel Laureate in Chemistry.


Lawrence May MD, Marpella’s Chief Medical Officer and Co-Founder, is a board certified internist with broad experience in clinical medicine, academics, media and business. Following residency he joined the faculty of the UCLA medical school where he directed the health services research center at the Wadsworth, VA hospital and served as a founder and co-director of the center for health enhancement education and research {CHEER} at UCLA. He continued on the clinical faculty after entering private practice, Dr. May has written many books and articles including a widely used textbook entitled Primary Care Medicine. Dr. May became an important formulator of nutritional products and served as executive vice president for medical and scientific affairs for Herbalife International. He has appeared in the media, lectured internationally, and consulted to industry and medical institutions, as well as serving on their boards. Dr. May previously served as Chief Medical Officer of Tauriga Sciences.  He was also a founder of Physician’s Therapeutics and helped develop its parent company, Targeted Medical Pharma. He is an advisor to Stock News Now (SNN), writes for microcap review and evaluates biopharmaceutical companies as an investor. Dr. May received his undergraduate degree magna cum laude in economics from Harvard University (’70) where he was elected to Phi Beta Kappa. His medical degree was also earned at Harvard Medical School (’74) and residency in internal medicine was served at Massachusetts General Hospital.

Q: What is the connection between Marpella and Tauriga Sciences?

A: The Marpella co-founders developed the natural wellness product line while at Tauriga Sciences and acquired all of the natural wellness assets in August, 2015.